Cellectar Biosciences Inc

-0.19 (-3.25%)
Earnings Announcements

Cellectar Biosciences Posts Q2 Loss Per Share $1.22

Published: 08/05/2022 14:08 GMT
Cellectar Biosciences Inc (CLRB) - Cellectar Reports Financial Results for Second Quarter 2022.
Q2 Loss per Share $1.22.
As of June 30, 2022, Company Had Cash and Cash Equivalents of $24.8 Million.
Believes Its Cash on Hand is Adequate to Fund Basic Budgeted Operations Into Q3 of 2023.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$1.24

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$1.33

More details on our Analysts Page.